Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 3.8 to 2.8.
Financials
Financial year 2025
APOTHEEK SINT BAVO from Boechout, company number BE0460304194, closed financial year 2025 with a result of € -20,076 after tax. For that financial year APOTHEEK SINT BAVO recorded a gross margin of € 194,671 and equity of € 401,080. Compared with financial year 2024, the result moved from € 22,355 to € -20,076. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 401,080
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -20,076
▼ still € 22,355 profit in 2024
Profit after tax over the fiscal year.
€ 89,757
▼ 36% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 394,475.
People and assets in 2025
2.8
▼ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 202,808
▼ 8% vs 2024
€ 72,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,405
▲ 67% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 198,955
▲ 64% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 28,510
▼ 27% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 320,828 | € 333,501 | € 271,330 | € 194,671 | ▼ 28% |
| Profit after taxes | € 54,830 | € 24,133 | € 22,355 | € -20,076 | ▼ € 42,431 |
| Equity | € 389,667 | € 398,801 | € 421,156 | € 401,080 | ▼ 5% |
| Total debts | € 196,509 | € 200,310 | € 160,754 | € 277,111 | ▲ 72% |
| Cash | € 209,471 | € 178,569 | € 139,682 | € 89,757 | ▼ 36% |
| Land & buildings | € 33,278 | € 27,439 | - | - | |
| Retained profit | € 383,062 | € 392,195 | € 414,550 | € 394,475 | ▼ 5% |
| Dividend | € 45,000 | € 15,000 | € 0 | € 0 | |
| Balance sheet total | € 586,176 | € 599,111 | € 581,909 | € 678,191 | ▲ 17% |
| Employees (FTE) | 4 | 3.8 | 3.2 | 2.8 | ▼ 0.4 |
Key figures of APOTHEEK SINT BAVO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK SINT BAVO?
What happened at APOTHEEK SINT BAVO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 20,076 (▼ € 42,431 vs 2024). Source: NBB ↗
- Libra Pharma BV became a director. NBB
- New establishment in Boechout. KBO
- Start of the company according to the CBE. KBO
In short
From € 54,830 profit in 2022 to € 20,076 loss in 2025.
Paid € 20,009 in corporate taxes since 2022.
Best year ever: 2022, with € 54,830 profit.
On average € 69,500 of value added per employee in 2025.
A new publication or filing at APOTHEEK SINT BAVO? We notify you, reason included.
Follow APOTHEEK SINT BAVODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DCV PHARMA, LIBRA PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK SINT BAVOBehind APOTHEEK SINT BAVO is Libra Pharma BV. The shares are held by DCV PHARMA (100%) and LIBRA PHARMA (100%).
Directors
According to the 2025 annual accounts
since 2025
Shareholders
100%
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Heuvelstraat 100
2530 Boechout
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
UPCLOUD, FI
Website info
Features
Security
Network
Details
- Company number
- 0460.304.194
- VAT number
- BE 0460.304.194
- Registered office
- Heuvelstraat 100, 2530 Boechout
- Names & denominations
- APOTHEEK SINT BAVO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 March 1997
- Peppol
- Active · Active since 6 Jan 2026
- Contact
- apotheeksintbavo.be
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers